Correction: BMC Cancer 22, 687 (2022)
https://doi.org/10.1186/s12885-022-09763-2
Following publication of the original article [1], the authors identified a production error. Figure 8 was not correctly processed by the publisher. The correct version of figure 8 is supplied in this correction article.
Fig. 8.
RMSD and RMSF of the SARS-CoV-2 Mpro complexes and DDP4 complexes. A The RMSD of Mpro. B The RMSD of DDP4. C The RMSD of inhibitor 11a and emetine. D The RMSD of omarigliptin and emetine. E The RMSF of Mpro. F The RMSF of DDP4
Reference
- 1.Zhang K, Wang K, Zhang C, et al. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses. BMC Cancer. 2022;22:687. doi: 10.1186/s12885-022-09763-2. [DOI] [PMC free article] [PubMed] [Google Scholar]